Home » Newsletters » BioWorld

BioWorld

March 31, 1994

View Archived Issues

GEN-PROBE TEST CLEARED FOR RELEASE

AUTOIMMUNE'S MS DRUG ENTERS PHASE III TRIALS

ALLELIX COMPLETES PHASE I TRIAL

APPOINTMENTS AND ADVANCEMENTS

ACTISITE CLEARED FOR MARKETING

CEL-SCI ENDS TALKS

BORON BIOLOGICALS GETS NIH GRANT FOR STUDY

AMGEN TO COLLABORATE WITH MIT

GENSET, SALK RECONCILE OVERLAPPING PATENTS

ONCOTRAC MOVES CLOSER TO MARKETING APPROVAL

MILLENNIUM, ROCHE FINALIZE $70M PACT